Nutrivention Trial Update | Urvi Shah, MD | IMS 2023

High-Fiber NUTRIVENTION Study for Delaying Progression of Myeloma | Urvi Shah, MD | #ASH24Подробнее

NUTRIVENTION Study | Urvi Shah, MDПодробнее

Food for Thought for Myeloma | Dr Urvi A. ShahПодробнее

Update on Research | Urvi Shah, MD | IMS 2023Подробнее

Exploring Dietary Intervention (NUTRIVENTION) in Myeloma: Impact on Progression and Immune ResponseПодробнее

Monoclonal Gammopathy of Unknown Significance | Urvi Shah, MD | IMS 2023Подробнее

Results from the GMMG Concept Trial in Germany | Lisa Leypoldt, MD | IMS 2023Подробнее

Nutrivention Trials | Urvi Shah, MD | ASH 2022Подробнее

Building a Dietary Evidence Symposium | Urvi Shah, MD | ASH 2022Подробнее

Trends in 11;14 FISH Testing for Myeloma | Linda Baughn, PH.D. | IMS 2023Подробнее

Dr. Urvi Shah Discusses Two Case Studies with Faculty | RT Raleigh, NC May 20, 2023Подробнее

Key Take Aways from IMS 2023 | Rafael Fonseca, MD | IMS 2023Подробнее

Understanding Cancer: Causes, Treatment & Prevention | Drs. Urvi Shah & Neil Iyengar | Ep 254Подробнее

Nutrition Heroes in Healthcare: Urvi Shah, MDПодробнее

Nutrition for Myeloma Patients: What We're Learning - Urvi Shah, MD | RT Raleigh, NC May 20, 2023Подробнее

Bispecifics | Urvi Shah, MD | ASH 2022Подробнее